Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stephanie Kapelski, Erna Cleiren, Ricardo M. Attar, Ulrike Philippar, Julien Häsler & Mark L. Chiu. (2019) Influence of the bispecific antibody IgG subclass on T cell redirection. mAbs 11:6, pages 1012-1024.
Read now
Read now
Sergey E Sedykh, Victor V Prinz, Valentina N Buneva & Georgy A Nevinsky. (2018) Bispecific antibodies: design, therapy, perspectives. Drug Design, Development and Therapy 12, pages 195-208.
Read now
Read now
Fatemeh Naddafi, Farshad H. Shirazi, Yeganeh Talebkhan, Maryam Tabarzad, Farzaneh Barkhordari, Zahra Aliabadi Farahani, Elham Bayat, Reza Moazzami, Fereidoun Mahboudi & Fatemeh Davami. (2018) A comparative study of the bispecific monoclonal antibody, blinatumomab expression in CHO cells and E. coli. Preparative Biochemistry & Biotechnology 48:10, pages 961-967.
Read now
Read now
Adam Zwolak, Anthony A. Armstrong, Susan H. Tam, Jose R. Pardinas, Dennis R. Goulet, Songmao Zheng, Kerry Brosnan, Eva Emmell, Jeffrey Luo, Gary L. Gilliland & Mark L. Chiu. (2017) Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn binding. mAbs 9:8, pages 1306-1316.
Read now
Read now
Articles from other publishers (31)
Mary L. Faber, Robyn A. A. Oldham, Archana Thakur, Mary Jo Rademacher, Ewa Kubicka, Theresa A. Dlugi, Steven A. Gifford, William M. McKillop, Nathan J. Schloemer, Lawrence G. Lum & Jeffrey A. Medin. (2023) Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity. Frontiers in Immunology 14.
Crossref
Crossref
Vivek Reddy Murthannagari, Ganesh Gonna Nandhi Krishnan, Kavitha Viswabramhana Manu, Chandu Thoti Jayachandraiah, Praharsh Kumar Mandadhi Rajendra & Syed Suhaib Ahmed. (2023) Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets. Value in Health Regional Issues 35, pages 87-94.
Crossref
Crossref
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, Fernando Souza-Fonseca-Guimaraes & Amirali Popat. (2023) Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy. Trends in Biotechnology 41:1, pages 77-92.
Crossref
Crossref
Yan Yang, Zheng Yang & Yun Yang. (2021) Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Reza Moazzami, Hasan Mirzahoseini, Leila Nematollahi, Farzaneh Barkhordari, Mozhgan Raigani, Fatemeh Hajari Taheri, Fereidoun Mahbudi & Fatemeh Davami. (2021) Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells. Iranian Biomedical Journal 25:4, pages 275-283.
Crossref
Crossref
Mariam Elshiaty, Hannah Schindler & Petros Christopoulos. (2021) Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer. International Journal of Molecular Sciences 22:11, pages 5632.
Crossref
Crossref
Seyed Samad Hosseini, Saeed Khalili, Behzad Baradaran, Negar Bidar, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Ahad Mokhtarzadeh & Michael R. Hamblin. (2021) Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials. International Journal of Biological Macromolecules 167, pages 1030-1047.
Crossref
Crossref
Zhaoqian Su, Bo Wang, Steven C. Almo & Yinghao Wu. (2020) Understanding the Targeting Mechanisms of Multi-Specific Biologics in Immunotherapy with Multiscale Modeling. iScience 23:12, pages 101835.
Crossref
Crossref
Muhammad Kalim, Muhammad Saleem Iqbal Khan & Jinbiao Zhan. (2020) Programmed cell death ligand‐1: A dynamic immune checkpoint in cancer therapy. Chemical Biology & Drug Design 95:6, pages 552-566.
Crossref
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Crossref
Raoufeh Ahamadi-Fesharaki, Abolfazl Fateh, Farzam Vaziri, Ghasem Solgi, Seyed Davar Siadat, Fereidoun Mahboudi & Fatemeh Rahimi-Jamnani. (2019) Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow. Molecular Therapy - Oncolytics 14, pages 38-56.
Crossref
Crossref
Weilei Hu, Guosheng Wang, Dongsheng Huang, Meihua Sui & Yibing Xu. (2019) Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. Frontiers in Immunology 10.
Crossref
Crossref
Roman V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Eugene D. Ponomarev & Irina V. Kholodenko. (2019) Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Current Medicinal Chemistry 26:3, pages 396-426.
Crossref
Crossref
Bo An, Ming Zhang, Jie Pu, Shichen Shen, Yang Qu, Yuan-Ju Chen, Shihan Huo, Xue Wang, Joseph Ryan Polli, Joseph P. Balthasar, Denis Herzog, Luca Ferrari, Roland F. Staack, Wolfgang F. Richter, Michael B. Otteneder, Lisa J. Benincosa, Shaolian Zhou, Faye Vazvaei & Jun Qu. (2019) High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent Strengths. Analytical Chemistry 91:5, pages 3475-3483.
Crossref
Crossref
Subhabrata Majumder, Wei Wang & Arun Alphonse Ignatius. (2019) Impact of Buffers on Colloidal Property and Aggregation Propensities of a Bispecific Antibody. Journal of Pharmaceutical Sciences 108:3, pages 1139-1147.
Crossref
Crossref
Jyoti Gupta, Mehboob Hoque, Md Fahim Ahmad, Rizwan Hasan Khan & M. Saleemuddin. (2019) Acid pH promotes bispecific antibody formation by the redox procedure. International Journal of Biological Macromolecules 125, pages 469-477.
Crossref
Crossref
N. Dimasi, R. Fleming, H. Wu & C. Gao. (2019) Molecular engineering strategies and methods for the expression and purification of IgG1-based bispecific bivalent antibodies. Methods 154, pages 77-86.
Crossref
Crossref
Ashley R. Sutherland, Md. Kausar Alam & C. Ronald Geyer. (2018) Post‐translational Assembly of Protein Parts into Complex Devices by Using SpyTag/SpyCatcher Protein Ligase. ChemBioChem 20:3, pages 319-328.
Crossref
Crossref
S. E. Sedykh & G. A. Nevinsky. (2019) Producing and prospects for the use of bispecific antibodies for the treatment of cancer. Advances in molecular oncology 5:4, pages 30-40.
Crossref
Crossref
Sahar Awwad & Ukrit Angkawinitwong. (2018) Overview of Antibody Drug Delivery. Pharmaceutics 10:3, pages 83.
Crossref
Crossref
Jun Li, Hui-Chen Hsu, John D. Mountz & John G. Allen. (2018) Unmasking Fucosylation: from Cell Adhesion to Immune System Regulation and Diseases. Cell Chemical Biology 25:5, pages 499-512.
Crossref
Crossref
Petra Verdino, Shane Atwell & Stephen J Demarest. (2018) Emerging trends in bispecific antibody and scaffold protein therapeutics. Current Opinion in Chemical Engineering 19, pages 107-123.
Crossref
Crossref
Mireya Paulina Velasquez, Challice L. Bonifant & Stephen Gottschalk. (2018) Redirecting T cells to hematological malignancies with bispecific antibodies. Blood 131:1, pages 30-38.
Crossref
Crossref
Dennis R. Goulet, Steven J. Orcutt, Adam Zwolak, Theo Rispens, Aran F. Labrijn, Rob N. de Jong, William M. Atkins & Mark L. Chiu. (2018) Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies. Journal of Biological Chemistry 293:2, pages 651-661.
Crossref
Crossref
Alexandra Cutillo, Joseph H. Chewning, Michael G. Hurst & Avi Madan-Swain. 2018. Pediatric Cancer Genetics. Pediatric Cancer Genetics
101
113
.
Adam Zwolak, Catherine N. Leettola, Susan H. Tam, Dennis R. Goulet, Mehabaw G. Derebe, Jose R. Pardinas, Songmao Zheng, Rose Decker, Eva Emmell & Mark L. Chiu. (2017) Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding. Scientific Reports 7:1.
Crossref
Crossref
Yang Chen & Yan Xu. (2017) Pharmacokinetics of Bispecific Antibody. Current Pharmacology Reports 3:3, pages 126-137.
Crossref
Crossref
Dennis R. Goulet, Adam Zwolak, Mark L. Chiu, Abhinav Nath & William M. Atkins. (2017) Diffusion of Soluble Aggregates of THIOMABs and Bispecific Antibodies in Serum. Biochemistry 56:17, pages 2251-2260.
Crossref
Crossref
Simon Krah, Christian Schröter, Carla Eller, Laura Rhiel, Nicolas Rasche, Jan Beck, Carolin Sellmann, Ralf Günther, Lars Toleikis, Björn Hock, Harald Kolmar & Stefan Becker. (2017) Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display. Protein Engineering Design and Selection.
Crossref
Crossref
Jyoti Gupta, Mehboob Hoque, Masihuz Zaman, Rizwan Hasan Khan & M. Saleemuddin. (2016) A detergent-based procedure for the preparation of IgG-like bispecific antibodies in high yield. Scientific Reports 6:1.
Crossref
Crossref
B. Vijayalakshmi Ayyar, Sushrut Arora & Richard O’Kennedy. (2016) Coming-of-Age of Antibodies in Cancer Therapeutics. Trends in Pharmacological Sciences 37:12, pages 1009-1028.
Crossref
Crossref